Among the individuals spotlighted is Harpinder Singh Chauhan, a 56-year-old British entrepreneur of Indian origin, who endured months of mistreatment while in U.S. Immigration and Customs Enforcement ...

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

Western researchers recently attracted $15M in CIHR project grants, created “to support the bold ideas and innovative work of Canada’s health researchers.” ...

WEIGHT loss jabs could help control asthma symptoms in obese people, a study suggests – and it’s not just about losing weight ...

Research exploring novel therapies to fight against bladder cancer and a world-first asthma study are among 18 Western projects drawing more than $15 ...

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

A common asthma inhaler has been recalled in the UK due to a labelling error that could mislead patients about their dosage.

The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond to or cannot receive topical corticosteroids, Leo Pharma announced in a ...

Vapendavir Demonstrated Consistent Benefit for Improving COPD Symptoms After Rhinovirus Infection, the Leading Cause of COPD Exacerbations Altesa to ...

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice ...